Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell immunoglobulin and mucin domain-containing protein 4 (TIMD4) is a type I transmembrane glycoprotein primarily expressed on antigen-presenting cells like macrophages and dendritic cells. It functions as a receptor for phosphatidylserine exposed on apoptotic cells, mediating their clearance (efferocytosis). TIMD4 also modulates adaptive immunity by interacting with TIM-1 on T cells, influencing T cell proliferation and differentiation, particularly Th2 responses. Its role in immune homeostasis makes it relevant to autoimmune disorders, allergic diseases, asthma, and cancer immunoregulation.
Not applicable - target not directly drugged, but modulated via its natural ligands
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell immunoglobulin and mucin domain-containing protein 4 (TIMD4).